(NKE) Nike - Ratings and Ratios
Footwear, Apparel, Accessories, Equipment, Digital
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.63% |
| Yield on Cost 5y | 1.22% |
| Yield CAGR 5y | 10.58% |
| Payout Consistency | 86.5% |
| Payout Ratio | 64.9% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 39.7% |
| Value at Risk 5%th | 55.0% |
| Relative Tail Risk | -15.62% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.38 |
| Alpha | -34.44 |
| CAGR/Max DD | -0.32 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.410 |
| Beta | 1.026 |
| Beta Downside | 0.943 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.40% |
| Mean DD | 29.45% |
| Median DD | 30.20% |
Description: NKE Nike December 02, 2025
Nike Inc. (NYSE:NKE) designs, develops, markets and sells athletic footwear, apparel, equipment and related services worldwide under brands such as Nike, Jordan, Converse and others. Its distribution network spans owned retail stores, e-commerce platforms, wholesale partners and licensed outlets, serving men, women and children across North America, Europe, Greater China, the Asia-Pacific and emerging markets.
Key recent metrics: FY 2023 revenue reached $51.2 billion, with digital sales growing 15% YoY and now representing roughly 30% of total revenue; direct-to-consumer (DTC) sales accounted for 38% of the mix, driving higher gross margins (≈ 45%). The company’s performance is sensitive to discretionary consumer spending, global footwear demand trends and supply-chain constraints, while a strong brand pipeline and continued expansion of its Nike App and membership ecosystem act as tailwinds.
For a deeper quantitative view of Nike’s valuation and risk profile, you may find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (2.52b TTM) > 0 and > 6% of Revenue (6% = 2.79b TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA -11.03pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 26.61% (prev 28.04%; Δ -1.44pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 3.53b > Net Income 2.52b (YES >=105%, WARN >=100%) |
| Net Debt (3.55b) to EBITDA (3.72b) ratio: 0.95 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.06 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.48b) change vs 12m ago -0.67% (target <= -2.0% for YES) |
| Gross Margin 41.13% (prev 44.60%; Δ -3.46pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 122.8% (prev 129.0%; Δ -6.22pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.07 (EBITDA TTM 3.72b / Interest Expense TTM 296.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.41
| (A) 0.33 = (Total Current Assets 24.02b - Total Current Liabilities 11.64b) / Total Assets 37.79b |
| (B) -0.02 = Retained Earnings (Balance) -727.0m / Total Assets 37.79b |
| (C) 0.06 = EBIT TTM 2.09b / Avg Total Assets 37.87b |
| (D) -0.04 = Book Value of Equity -982.0m / Total Liabilities 23.70b |
| Total Rating: 2.41 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 52.01
| 1. Piotroski 4.50pt |
| 2. FCF Yield 3.20% |
| 3. FCF Margin 6.47% |
| 4. Debt/Equity 0.78 |
| 5. Debt/Ebitda 0.95 |
| 6. ROIC - WACC (= -1.21)% |
| 7. RoE 18.43% |
| 8. Rev. Trend -24.60% |
| 9. EPS Trend -58.40% |
What is the price of NKE shares?
Over the past week, the price has changed by +6.97%, over one month by -6.39%, over three months by -11.43% and over the past year by -16.06%.
Is NKE a buy, sell or hold?
- Strong Buy: 13
- Buy: 6
- Hold: 20
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the NKE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 77.2 | 26.2% |
| Analysts Target Price | 77.2 | 26.2% |
| ValueRay Target Price | 54.5 | -11% |
NKE Fundamental Data Overview December 27, 2025
P/E Trailing = 35.6316
P/E Forward = 37.7358
P/S = 1.9364
P/B = 6.2969
P/EG = 2.5157
Beta = 1.291
Revenue TTM = 46.51b USD
EBIT TTM = 2.09b USD
EBITDA TTM = 3.72b USD
Long Term Debt = 7.02b USD (from longTermDebt, last quarter)
Short Term Debt = 507.0m USD (from shortTermDebt, last fiscal year)
Debt = 11.02b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 3.55b USD (from netDebt column, last fiscal year)
Enterprise Value = 94.11b USD (90.07b + Debt 11.02b - CCE 6.97b)
Interest Coverage Ratio = 7.07 (Ebit TTM 2.09b / Interest Expense TTM 296.0m)
FCF Yield = 3.20% (FCF TTM 3.01b / Enterprise Value 94.11b)
FCF Margin = 6.47% (FCF TTM 3.01b / Revenue TTM 46.51b)
Net Margin = 5.43% (Net Income TTM 2.52b / Revenue TTM 46.51b)
Gross Margin = 41.13% ((Revenue TTM 46.51b - Cost of Revenue TTM 27.38b) / Revenue TTM)
Gross Margin QoQ = 40.60% (prev 42.18%)
Tobins Q-Ratio = 2.49 (Enterprise Value 94.11b / Total Assets 37.79b)
Interest Expense / Debt = 0.82% (Interest Expense 90.0m / Debt 11.02b)
Taxrate = 20.72% (207.0m / 999.0m)
NOPAT = 1.66b (EBIT 2.09b * (1 - 20.72%))
Current Ratio = 2.06 (Total Current Assets 24.02b / Total Current Liabilities 11.64b)
Debt / Equity = 0.78 (Debt 11.02b / totalStockholderEquity, last quarter 14.09b)
Debt / EBITDA = 0.95 (Net Debt 3.55b / EBITDA 3.72b)
Debt / FCF = 1.18 (Net Debt 3.55b / FCF TTM 3.01b)
Total Stockholder Equity = 13.69b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.68% (Net Income 2.52b / Total Assets 37.79b)
RoE = 18.43% (Net Income TTM 2.52b / Total Stockholder Equity 13.69b)
RoCE = 10.11% (EBIT 2.09b / Capital Employed (Equity 13.69b + L.T.Debt 7.02b))
RoIC = 7.59% (NOPAT 1.66b / Invested Capital 21.87b)
WACC = 8.80% (E(90.07b)/V(101.08b) * Re(9.80%) + D(11.02b)/V(101.08b) * Rd(0.82%) * (1-Tc(0.21)))
Discount Rate = 9.80% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.71%
[DCF Debug] Terminal Value 72.02% ; FCFE base≈4.69b ; Y1≈4.66b ; Y5≈4.89b
Fair Price DCF = 54.19 (DCF Value 64.45b / Shares Outstanding 1.19b; 5y FCF grow -1.27% → 3.0% )
EPS Correlation: -58.40 | EPS CAGR: -12.38% | SUE: 2.09 | # QB: 2
Revenue Correlation: -24.60 | Revenue CAGR: 3.63% | SUE: 0.48 | # QB: 0
EPS next Quarter (2026-02-28): EPS=0.29 | Chg30d=-0.185 | Revisions Net=-15 | Analysts=18
EPS current Year (2026-05-31): EPS=1.60 | Chg30d=-0.082 | Revisions Net=-16 | Growth EPS=-25.9% | Growth Revenue=+0.8%
EPS next Year (2027-05-31): EPS=2.41 | Chg30d=-0.121 | Revisions Net=-13 | Growth EPS=+50.5% | Growth Revenue=+4.3%
Additional Sources for NKE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle